This medication is a gadolinium based contrast agent, prescribed for visualization of brain along with with magnetic resonance imaging (MRI).
Contraindicated in patients with hypersensitivity.
IV- The recommended dose is 0.2 mL/kg, (0.1 mmol/kg) as bolus injection.
It comes as a powder for injection (diluted with fluid) to be administered by a healthcare provider into the vein.
• Caution should be exercised in patients with history of acute kidney injury, impaired elimination of GBCAs, any allergy, who are taking other medications.
• Patient with impaired elimination of GBCAs may experience with increased risk of Nephrogenic Systemic Fibrosis.
• Monitor patients closely for need of emergency breathing support.
• Most frequent:
Nausea, headache, injection site pain, injection site coldness and burning sensation.
• Heart: Abnormal heart rhythm, fast or slow heart rate.
• Immune System: Hypersensitivity/anaphylactoid reactions including heart arrest, respiratory arrest, blue or purple coloration of the skin or mucous, throat swelling, asthma, eye inflammation, eyelid swelling, increased tears, increased sweating and hives.
• Central Nervous System: Coma, convulsion, fainting, lightheadedness, smell loss, tremor
• Musculoskeletal: Muscle contracture, muscle weakness.
• Gastrointestinal: Diarrhea, increased salivary secretion.
• General: Uneasiness and fever.
• Skin: Inflammation of a vein
Avoid excess dosage.
Store it at controlled room temperature (25°C).
Subscribe to our Free Newsletters!
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...View All